Follow
Giuliana S Zuccoli
Giuliana S Zuccoli
Verified email at dac.unicamp.br
Title
Cited by
Cited by
Year
Morphological, cellular, and molecular basis of brain infection in COVID-19 patients
F Crunfli, VC Carregari, FP Veras, LS Silva, MH Nogueira, ASLM Antunes, ...
Proceedings of the National Academy of Sciences 119 (35), e2200960119, 2022
1592022
The energy metabolism dysfunction in psychiatric disorders postmortem brains: focus on proteomic evidence
GS Zuccoli, VM Saia-Cereda, JM Nascimento, D Martins-de-Souza
Frontiers in neuroscience 11, 277593, 2017
1212017
SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability
F Crunfli, VC Carregari, FP Veras, PH Vendramini, AGF Valença, ...
MedRxiv, 2020.10. 09.20207464, 2021
912021
Proteomics and molecular tools for unveiling missing links in the biochemical understanding of schizophrenia
JM Nascimento, S Garcia, VM Saia‐Cereda, AG Santana, ...
PROTEOMICS–Clinical Applications 10 (12), 1148-1158, 2016
182016
Digging deeper in the proteome of different regions from schizophrenia brains
G Reis-de-Oliveira, GS Zuccoli, M Fioramonte, A Schimitt, P Falkai, ...
Journal of proteomics 223, 103814, 2020
152020
Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms
V Mendes de Almeida, DF Engel, MF Ricci, CS Cruz, ÍS Lopes, DA Alves, ...
Gut Microbes 15 (2), 2249146, 2023
122023
Gut microbiota from patients with mild COVID-19 cause alterations in mice that resemble post-COVID syndrome
VM de Almeida, DF Engel, MF Ricci, CS Cruz, IS Lopes, DA Alves, ...
Research Square, 2022
112022
Combining patient-reprogrammed neural cells and proteomics as a model to study psychiatric disorders
GS Zuccoli, D Martins-de-Souza, PC Guest, SK Rehen, JM Nascimento
Proteomic Methods in Neuropsychiatric Research, 279-287, 2017
112017
Effects on glial cell glycolysis in schizophrenia: an advanced aging phenotype?
GS Zuccoli, PC Guest, D Martins-de-Souza
Reviews on Biomarker Studies in Aging and Anti-aging Research, 25-38, 2019
102019
Proteomic signatures of schizophrenia-sourced iPSC-derived neural cells and brain organoids are similar to patients' postmortem brains
JM Nascimento, VM Saia-Cereda, GS Zuccoli, G Reis-de-Oliveira, ...
Cell & bioscience 12 (1), 189, 2022
92022
Synapse preservation and decreased glial reactions following ventral root crush (VRC) and treatment with 4‐hydroxy‐tempo (TEMPOL)
AB Spejo, CB Teles, GS Zuccoli, ALR Oliveira
Journal of neuroscience research 97 (4), 520-534, 2019
92019
Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC-based neurodevelopmental model for schizophrenia
GS Zuccoli, JM Nascimento, PM Moraes-Vieira, SK Rehen, ...
European Archives of Psychiatry and Clinical Neuroscience 273 (8), 1649-1664, 2023
82023
SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability. medRxiv 2021
F Crunfli, VC Carregari, FP Veras, PH Vendramini, AG Valença, ...
Google Scholar, 0
8
Exogenous succinate impacts mouse brown adipose tissue mitochondrial proteome and potentiates body mass reduction induced by liraglutide
RS Gaspar, J Delafiori, G Zuccoli, VC Carregari, TP Prado, J Morari, ...
American Journal of Physiology-Endocrinology and Metabolism 324 (3), E226-E240, 2023
72023
Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes
GS Zuccoli, G Reis-de-Oliveira, B Garbes, P Falkai, A Schmitt, HI Nakaya, ...
European archives of psychiatry and clinical neuroscience 271, 1579-1586, 2021
62021
Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes
V de Almeida, G Seabra, G Reis-de-Oliveira, GS Zuccoli, P Rumin, ...
European Archives of Psychiatry and Clinical Neuroscience 272 (7), 1311-1323, 2022
32022
Zika virus strains and dengue virus induce distinct proteomic changes in neural stem cells and neurospheres
JM Nascimento, D Gouvêa-Junqueira, GS Zuccoli, CSG Pedrosa, ...
Molecular neurobiology 59 (9), 5549-5563, 2022
32022
Molecular Findings Guiding the Modulation of the Endocannabinoid System as a Potential Target to Treat Schizophrenia
GS Zuccoli, C Brandão-Teles, GM Vieira, FV Gomes, F Crunfli
Neuroproteomics as a Tool for Understanding Schizophrenia, 89-103, 2022
32022
Protein succinylation and malonylation as potential biomarkers in schizophrenia
BJ Smith, C Brandão-Teles, GS Zuccoli, G Reis-de-Oliveira, M Fioramonte, ...
Journal of personalized medicine 12 (9), 1408, 2022
22022
Mitochondrial Dysregulation and the Influence in Neurodegenerative Diseases
GS Zuccoli, VC Carregari
Understanding PTMs in Neurodegenerative Diseases, 109-118, 2022
12022
The system can't perform the operation now. Try again later.
Articles 1–20